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Abstract
Background and Objectives: Angiogenesis is the process of forming new capillary vessels from existing ones. This process is implicated
in tumour growth, metastasis and wound healing. During tumour metastasis, angiogenesis is amplified as new capillaries are needed for
cancer to spread. However, when this process is inhibited, wound healing is impaired. Cyclooxygenase-2 (COX-2), nitric oxide synthase
(NOS) and lipoxygenase (LOX) are some of the enzymes that are highly expressed during angiogenesis and therefore provide a useful
way to detect angiogenesis. Some medicinal plants have shown to possess angiogenetic-modulating properties, which has led to the
development of anti-angiogenic drugs for the treatment of cancer. Spirostachys africana  sond has been used historically to treat open
wounds, ulcers and cancer. Nevertheless, its mechanism of action is still unclear. The aim of this study was to determine mechanisms of
anticancer and wound healing activities of S. africana  by evaluating its effects on the proliferation of MCF-7 cells and on the activities of
COX-2, LOX and NOS. Materials and Methods: The dried plant materials were extracted with water and sequentially with organic solvents
in their order of increasing polarity. Extracts were screened for cell growth inhibitory activity against breast cancer MCF-7 cells and for
selectivity against normal breast MCF-10A cells. Extracts that showed growth inhibitory activity with IC50 values <10 µg mLG1 were further
evaluated for effects on COX-2, LOX and NOS enzymatic activity. Results: The non-polar extracts of all plant parts had anti-proliferation
activity with IC50 of 10 µg mLG1 or lower. All the leaf extracts showed selectivity for MCF-7 breast cancer. The selected extracts also induced
NOS activity and inhibited LOX and COX-2 activity in a concentration dependent manner. Conclusion: It was concluded that the selected
extracts may suppress angiogenesis by inhibiting COX-2 and LOX and induce apoptosis by increasing NOS activity. Spirostachys africana
was found to contain tannins, glycosides, saponins and alkaloids which could be responsible for the biological activity observed.
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INTRODUCTION
Angiogenesis is the processes of forming new capillary
vessels from existing ones. It is a normal biological process
that occurs during female reproductive cycle and wound
healing1. Studies have shown that abnormal angiogenesis is
related to tumour growth and tumour progression to a
metastatic phenotype2. For metastasis to occur, new vessels
are required to supply the tumour with nutrients and oxygen1.
Angiogenesis also involves growth factors, cytokines and
enzymes such as cyclooxygenases (COX), nitric oxide synthase
(NOS) and lipoxygenases (LOX).
The  COX  are  enzymes  that  catalyse  the  oxidation  of
a wide variety of xenobiotics, including prostaglandins3.
Cyclooxygenase-2 (COX-2) is inducible and functions in
inflammation and tumour angiogenesis4,5. The LOX are a
group of enzymes with a non-heme iron atom that catalyse
the oxidation of polyunsaturated fatty acids like arachidonic
acid6. The expression of 12-LOX in prostate cancer was found
to  induce  tumour  angiogenesis7.  More  5-LOX  transcripts
were found in brain tumours than in normal bovine brain and
5(S)-hydrooxyeicosa-6E,8C,11Z,14Z-tetraenoic acid (5-HETE),
a product of 5-LOX, stimulated the growth of breast cancer
cells, whereas a 5-LOX selective inhibitor reduced cell
growth8,9. NOS catalyse the formation of (NO) from L-arginine.
Cianchi et al.10 found elevated levels of inducible nitric oxide
synthase (iNOS) and vascular endothelial growth factor (VEGF)
in colorectal cancer and a high activity of iNOS in metastatic
tumours than in non-metastatic ones. Thus, COX-2, LOX and
NOS have been selected as the focus of this study due to their
significant role in angiogenesis and their involvement in
tumour initiation and growth.
Spirostachys africana  sond is a member of the family
Euphorbiaceae. The plant is indigenous to the southern and
central regions of Africa11. Historically, the plant has been used
to treat both cancer and acute wounds. In South Africa, its
stem and bark are used to treat stomach pains, stomach
ulcers, coughs and eye complaints12-16. Additionally, in
Tanzania, its stem barks and roots are used to treat cervical,
colon, breast and liver cancer17. There is no scientific
information on the anti-cancer and wound healing ability of
this plant. Hence, this study aimed to investigate the effects of
S. africana  on the process of angiogenesis, which is implicated
in both cancer and wound healing. This study determined the
effects of S. africana  on the growth of MCF-7 breast cancer cell
line and its angiogenesis modulating properties, by evaluating
its  inhibitory  effects  on  COX-2,  LOX  and  NOS.  The  MCF-7
cell line was selected for the study because it has the
characteristics  of  a  tumor  and  expresses  the  selected
enzymes in high levels18,19.
MATERIALS AND METHODS
Plant collection and extraction: This study was conducted at
the Central University of Technology and the University of the
Free State, in Bloemfontein, South Africa, from April, 2017 until
September, 2018. The plants were collected from Pretoria and
Kruger National Park in Gauteng and Limpopo Provinces of
South Africa during the summer season. The plants were
authenticated by a botanist in the Department of Botany at
University  of  the  Free  State.  The  plants  were  washed  with
tap water upon arrival at the laboratory and dried at room
temperature.  The  dried  plant  material  was  ground,
weighed and then extracted with water or organic solvents
(hexane, DCM, ethyl acetate and methanol) in their order of
increasing polarity. The plant-solvent mixtures were left to
shake for 48 h before filtering. The filtrates were concentrated
by freeze  drying  (water  extract)  and  rotatory  evaporation
(organic extracts). The percentage yields were calculated.
Phytochemical analysis: The powdered plant material was
subjected to different methods to determine the presence of
phytosterols, pentose, tannins, glycosides, triterpenoids,
anthraquinones, saponins, flavonoids and alkaloids20.
Cell culturing: The MCF-7 cells were grown in DMEM media
supplemented with 10% Fetal Bovine Serum (FBS) and 0.6%
streptomycin. The culture was maintained at 37EC in
humidified atmosphere and concentrated with CO2 (5%).
Following the methods described by Huang et al.20, the cells
were sub-cultured once they reached ~80% confluency.
Subsequently, the cell viability was determined by trypan blue
staining and automated cell counter was used to obtain a cell
concentration of 1×105 cells mLG1, which was used in all
experiments. Thereafter, the cells were plated in 96-well plate
and incubated for 24 h to adhere. After the 24 h incubation
period, the media was aspirated and cells were treated with
100 µL of 100, 10 and 1 µg mLG1 dilutions of the crude extracts
(in triplicate). Aliquots of 100 µL of media were added to make
a final volume of 200 µL. The plates were further incubated for
48 h. Cell proliferation was measured by MTT assay following
incubation21 and absorbance was read at 540 nm wavelength.
Selectivity  was  assessed  on  non-cancerous  normal
MCF-10A breast cells. Cells were grown in EMEM media
supplemented with epidermal growth factors and 10% FBS.
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Nitric oxide synthase activity: The Griess reagent method
was used to measure the amount of NO produced by the cells
after exposure to the plant extracts22. The assay relies on a
diazotization  reaction  to  detect  nitrite  (NOG2),  which  is  a
stable  form  of  NO.  The  NOG2  reacts  with  sulfanilamide  and
N-1-naphthylethylenediamine dihydrochloride (NED) under
acidic  (phosphoric  acid)  conditions.  In  this  assay,  cells
(1×105  cells  mLG1)  were  incubated  with  different
concentrations  of  the  extracts  for  48  h.  The  cell  culture
supernatant (100 µL) was obtained from the culture and
mixed with sulfanilamide (100 µL). The mixture was incubated
for 10 min at room temperature. The NED solution (100 µL)
was then added. The experiment was incubated for 10 min.
Thereafter, the absorbance was measured at 550 nm. The
nitrite (NOG2) concentration was calculated from the NOG2
standard curve. Cells without extract were used as a negative
control.
LOX activity assay: Lipoxygenase activity was determined
using the lipoxygenase activity assay kit obtained from
BioVision Life Science in South Africa. In this assay, LOX
converts  its  substrate  into  an  intermediate  that  reacts  with
the  probe  and  in  doing  so,  it  generates  a  fluorescent
product that is measured with a spectrophotometer. The cells
(4×105 cells mLG1) were homogenised with 100 µL ice-cold
LOX buffer and kept on ice for 10 min, followed by
centrifugation at 10 000×g for 15 min. The cell lysate (10 µL)
was then mixed with 10 µL plant extract at different
concentrations (100, 10 and 1 µg mLG1), 20 µl LOX substrate,
2 µL LOX probe and 78 µL of LOX buffer. The mixture was
immediately placed on the fluorescence plate reader
(PHERAstar FS, BMG)  and  the fluorescence was measured at
30  sec  interval  for  30  min,  at  an  excitation  wavelength  of
500 nm and emission wavelength of 536 nm. A standard curve
was generated from the LOX substrate and pure LOX enzyme
supplied. The LOX inhibitor was used as a positive control. The
experiment was performed in duplicates and repeated twice.
Cyclooxygenase-2  activity  assay:  Inhibition  of  COX-2  in
MCF-7 cells was determined using COX activity kit from
BioVision    Life    Science    in    South    Africa.    The    cells
(4×105 cells mLG1) were homogenised with 100 µL ice-cold
LOX buffer and kept on ice for 10 min, followed by
centrifugation at 10 000×g for 15 min. In each well, cell lysate
(10 µL) was mixed with 10 µL plant extract at different
concentrations, viz: (100, 10 and 1 µg mLG1), 2 µL COX probe,
4 µL diluted COX cofactor and 74 µL COX assay buffer. The
mixture was immediately placed on the fluorescence plate
reader and the fluorescence was measured at 30 sec interval
for 30 min, at an excitation wavelength of 536 nm and
emission wavelength of 587 nm. A standard curve was
generated using the supplied standard. The COX-2 inhibitor
(supplied) was used as a positive control. The experiment was
performed in duplicates and repeated twice.
Statistical  analysis:  The  values  are  presented  as  the
mean±standard deviation (SD) for 2 experiments performed
independently.
RESULTS
The yields of the extraction process are summarized in
Table 1. Methanol extracts had the highest yield for both
leaves and barks while the lowest yield was observed in DCM
stem extract.
Phytochemical analysis: Phytochemical composition of the
3 parts of S. africana  plant viz: Leaves, stems and barks was 
analysed for the presence of various secondary metabolites.
Tannins, glycosides, saponins and alkaloids were present in all
plant parts. All the phytochemicals tested were detected in
the bark except flavonoids, which were absent in all plant
parts (Table 2).
Cell  growth  inhibition  studies:  Figure  1  illustrates  cell
growth   inhibition   of   MCF-7   cells   following   exposure   to
S. africana  extracts. The bark had 4 extracts: Hexane (TB1),
dichloromethane (TB2), methanol (TB3) and ethyl acetate 
(TB4). From the 4 extracts, the dichloromethane extract (TB2)
had the highest anti-proliferative activity, with concentrations
of 10 and 1 µg mLG1 inhibiting more than 50% of the culture
(IC50). All the leaf extracts showed considerable activity with
IC50 ranging from 1-10 µg mLG1. For the stem extracts, only the
DCM extract (TS2) indicated anti-proliferation activity at
concentrations of <10 µg mLG1.
Table 1: Percentage yields obtained from extraction of S. africana  plant material
with various solvents
Plant parts Hexane (%) DCM (%) MeOH (%) Ethyl acetate (%)
Leaves 0.5 0.70 21.1 0.2
Barks 5.9 5.10 39.9 5.9
Stems 1.9 0.02 ND ND
ND: Not done
Table 2: Phytochemical screening results of S. africana  plant parts
Phytochemicals Stem Leaf Bark
Phytosterols + - +
Pentose - - +
Tannins + + +
Glycosides + + +
Triterpenoids + - +
Anthraquinones - - +
Saponins + + +
Flavonoids - - -
Alkaloids + + +
+: Present, -: Absent
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Fig. 1: Cell growth inhibitory effects of S. africana  extracts on MCF-7 cells
TB: Bark extract, TL: Leaf extract, TS: Stem extract, 1: Hexane, 2: DCM, 3: Methanol, 4: Ethyl acetate
Fig. 2: Inhibitory effects of S. africana  bark, stem and leaf extracts on normal human breast MCF-10A cell growth
TL: Leaf extract, TB: Bark extract, TS: Stem extract, 1: Hexane, 2: DCM, 3: Methanol, 4: Ethyl acetate
The hexane and DCM extracts of the bark (TB1 and TB2),
all the leaf extracts (TL1-TL4) and the DCM extract of the stem
(TS2), achieved IC50 at a concentration of 10 µg mLG1 and were
selected for further studies.
Selectivity: Selectivity of the selected extracts was studied by
determining their anti-proliferative activity against the normal
human breast MCF-10A cells. All the leaf extracts showed low
anti-proliferation activity against MCF-10A cells as compared
to activity against MCF-7 cells (Fig. 2).
Generally, extracts that exhibited IC50 of <10 µg mLG1
against         MCF-7         showed         reduced         inhibition
(20% inhibition and less) at the same concentration against
the  normal  breast  cell  line.  The  leaf  extracts  indicated
minimal  activity  (<10%  growth  inhibition)  against  the
normal breast cells at a concentration of 1 µg mLG1. The
hexane leaf extract (TL1), which had the highest cytotoxic
activity against the breast cancer cells, showed the least
activity  on  MCF-10A  cells,  suggesting  some  selectivity  for
MCF-7 cells.
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Fig. 3: Effects of S. africana  extracts on NOS
TB: Bark extract, TL: Leaf extract, 1: Hexane, 2: DCM, 3: Methanol, 4: Ethyl acetate
Fig. 4: Inhibition of activity of COX-2 by S. africana  extracts
TB: Bark extract, TL: Leaf extract, 1: Hexane, 2: DCM, 3: Methanol, 4: Ethyl acetate, Tve control: Positive control (activity of pure enzyme supplied), Enz+inh: Pure
enzyme with celecoxib (COX-2 inhibitor)
NOS inhibition studies: The effects of plant extracts on the
activity of NOS are depicted in Fig. 3. The results demonstrate
that the levels of NO produced by the cells following exposure
to  the  extracts  increased  with  increasing  concentration  of
the extracts.
The  hexane  and  DCM  extracts  of  the  both  the  leaf
and   bark  (TL1,  TL2,  TB1  and  TB2),  which  had  exhibited
the highest cell  growth inhibition against MCF-7 cells,
induced  high  levels  of  NO  (over  1000  and  2000  µM,
respectively) as compared to cells that were not exposed to
the  extracts.  This  implies  a  strong  association  between  the
high levels of NO and cell death.
COX-2 inhibition studies: The results depicted in Fig. 4 shows
that COX-2 was inhibited by all selected S. africana  extracts in
a concentration  dependent manner. The hexane extract of
the bark-(TB1) exhibited the highest inhibition of enzyme
activity (~0.26 pmol µLG1 at 100 µg mLG1), as compared to
celecoxib, a  known  inhibitor  of  COX-2,  which  had  activity
of  9.3 pmol µLG1.
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Fig. 5: Effects of selected extracts of S. africana  on the activity of LOX enzyme
TB: Bark extract, TL: Leaf extract, PC: Positive control (cell lysate plus the supplied inhibitor), Sample: Cells without extract (negative control), 1: Hexane, 2: DCM,
3: Methanol
LOX  inhibition  studies:  The  LOX  activity  was  determined
by measuring the Relative Fluorescence Units (RFU) and
deducing concentration from the LOX standard probe. The
results are illustrated in Fig. 5. Extracts inhibited LOX activity in
a concentration dependant manner with methanol leaf extract
(TL3) demonstrating the highest inhibition (0.81 pmol µLG1) at
100 µg mLG1. The negative control (cells without the extract)
had the highest activity of 0.91 pmol µLG1.
DISCUSSION
The findings of this study confirm earlier research that
many secondary metabolites such as tannins, glycosides,
saponins and alkaloids are present in the S. africana. Previous
studies reported that tannins have anticancer activity23,24,
while      saponins,      flavonoids      and      glycosides      have
anti-inflammatory and antioxidant activity25-27, both of which
are implicated in anticancer processes. In addition, the stem
and  the  bark  of  S.  africana  ethanolic  extracts  were  found
to  contain  diterpenoids  and  triterpenoids28.  Similarly,
triterpenoids were detected in the same parts in the current
study. It was also observed that all the non-polar extracts had
the highest cell growth inhibitory activity. This suggests that
the active phytochemicals are non-polar. The non-polar and
semi-polar phytochemicals that could be present in the plant
include alkaloids, phytosterols and triterpenoids29.
The non-polar leaf and bark extracts which showed the
highest inhibition of MCF-cells with IC50 values of 10  µg mLG1
and lower, also resulted in high production of NO. High levels
of NO have been reported to promote apoptosis30. Results
suggest that the non-polar leaf and bark extracts of S. africana
induced the iNOS (inducible-nitric oxide synthase) to produce
more NO, which promoted apoptosis.
The literature shows that LOX and COX-2 are highly
expressed in tumour angiogenesis31. Inhibition of these
enzymes inhibits tumour angiogenesis32. In this study, all leaf
extracts and DCM bark extract of S. africana  inhibited COX-2
activity more than the known COX-2 inhibitor. These extracts
further inhibited the LOX enzyme. This implies that the
extracts could inhibit the process of angiogenesis, which is
associated with tumour initiation, growth and metastasis.
CONCLUSION
The  S.  africana  leaves  had  few  but  essential
phytochemicals that are known to have anti-inflammatory and
anticancer activities. The leaf extracts selectively inhibited
growth of breast cancer MCF-7 cells over normal breast cells
and induced NO production. The extracts also inhibited COX-2
and LOX activities in a concentration dependent manner in
MCF-7 cells. The results show selective inhibition of MCF-7
breast cancer cells, a correlation between cell death and
stimulation of NOS and an inhibition of COX-2 and LOX
enzymes.
The authors are not aware of similar studies that have
been conducted on this plant.
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This study adds to the search for novel anti-cancer drugs
from medicinal plants and contributes scientific knowledge on
mechanisms exerted by medicinal plants on biological
processes involved in cancer initiation and growth.
Spirostachys africana  exhibited anti-angiogenesis properties
selectively on breast cancer cells. Active constituents could be
isolated and further studied as potential anti-angiogenic
chemotherapeutic lead compounds.
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